In vitro anticancer drug sensitivity testing

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Accurate prediction of antitumor drug efficacy is crucial for effective cancer treatment.
• Short-term human tumor cultures offer a model for evaluating drug responses.
• 3H-thymidine incorporation into DNA serves as a measure of cellular proliferation and drug effect.

Purpose of the Study:

• To investigate the utility of 3H-thymidine incorporation into DNA for assessing antitumor drug sensitivity in human tumor cultures.
• To correlate in vitro drug sensitivity testing with clinical outcomes in cancer patients.

Main Methods:

• Short-term cultures of human tumor samples were established.
• The effect of various antitumor drugs on 3H-thymidine incorporation into DNA was measured.
• Drug sensitivity was tested in tumor samples from 104 patients.
• Clinical responses of 53 treated patients were analyzed and compared to laboratory results.

Main Results:

• The 3H-thymidine incorporation assay was applied to diverse malignant tumors.
• A significant correlation (88.7%) was observed between in vitro drug sensitivity testing and clinical response in patients.
• This indicates the predictive value of the laboratory method.

Conclusions:

• In vitro drug sensitivity testing using 3H-thymidine incorporation into DNA is a reliable method for predicting clinical response to antitumor drugs.
• This approach can aid in selecting optimal therapeutic strategies for cancer patients.
• The findings support the use of personalized medicine in oncology.